☰

Alessandra Castegna, Ph.D. - Publications

Affiliations: 
University of Kentucky, Lexington, KY 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=41
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Butterfield DA, Favia M, Spera I, Campanella A, Lanza M, Castegna A. Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases. Molecules (Basel, Switzerland). 27. PMID 35164216 DOI: 10.3390/molecules27030951  0.506
2018 Costiniti V, Spera I, Menabò R, Palmieri EM, Menga A, Scarcia P, Porcelli V, Gissi R, Castegna A, Canton M. Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury. Biochimica Et Biophysica Acta. PMID 29953926 DOI: 10.1016/J.Bbadis.2018.06.018  0.389
2017 Punzi G, Porcelli V, Ruggiu M, Hossain F, Menga A, Scarcia P, Castegna A, Gorgoglione R, Pierri CL, Laera L, Lasorsa FM, Paradies E, Pisano I, Marobbio CMT, Lamantea E, et al. SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency. Human Molecular Genetics. PMID 29211846 DOI: 10.1093/Hmg/Ddx419  0.342
2017 Profilo E, Peña-Altamira LE, Corricelli M, Castegna A, Danese A, Agrimi G, Petralla S, Giannuzzi G, Porcelli V, Sbano L, Viscomi C, Massenzio F, Palmieri EM, Giorgi C, Fiermonte G, et al. Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. Biochimica Et Biophysica Acta. PMID 28235644 DOI: 10.1016/J.Bbadis.2017.02.022  0.388
2016 Palmieri EM, Menga A, Lebrun A, Hooper DC, Butterfield DA, Mazzone M, Castegna A. Blockade of glutamine synthetase enhances inflammatory response in microglial cells. Antioxidants & Redox Signaling. PMID 27758118 DOI: 10.1089/Ars.2016.6715  0.458
2016 Iacobazzi V, Infantino V, Castegna A, Menga A, Palmieri EM, Convertini P, Palmieri F. Mitochondrial carriers in inflammation induced by bacterial endotoxin and cytokines. Biological Chemistry. PMID 27727142 DOI: 10.1515/Hsz-2016-0260  0.306
2016 Butterfield DA, Palmieri EM, Castegna A. Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Review of Proteomics. PMID 26837425 DOI: 10.1586/14789450.2016.1149470  0.525
2014 Vozza A, Parisi G, De Leonardis F, Lasorsa FM, Castegna A, Amorese D, Marmo R, Calcagnile VM, Palmieri L, Ricquier D, Paradies E, Scarcia P, Palmieri F, Bouillaud F, Fiermonte G. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proceedings of the National Academy of Sciences of the United States of America. 111: 960-5. PMID 24395786 DOI: 10.1073/Pnas.1317400111  0.374
2014 Canton M, Castegna A, Menabo' R, Spera I, Palmieri EM, Di Lisa F. 31Metabolomic identification of substrates for monoamine oxidases in hearts subjected to oxidative stress Cardiovascular Research. 103: S4.3-S4. DOI: 10.1093/Cvr/Cvu077.3  0.433
2011 Castegna A, Palmieri L, Spera I, Porcelli V, Palmieri F, Fabis-Pedrini MJ, Kean RB, Barkhouse DA, Curtis MT, Hooper DC. Oxidative stress and reduced glutamine synthetase activity in the absence of inflammation in the cortex of mice with experimental allergic encephalomyelitis. Neuroscience. 185: 97-105. PMID 21536110 DOI: 10.1016/J.Neuroscience.2011.04.041  0.482
2010 Castegna A, Scarcia P, Agrimi G, Palmieri L, Rottensteiner H, Spera I, Germinario L, Palmieri F. Identification and functional characterization of a novel mitochondrial carrier for citrate and oxoglutarate in Saccharomyces cerevisiae. The Journal of Biological Chemistry. 285: 17359-70. PMID 20371607 DOI: 10.1074/Jbc.M109.097188  0.321
2006 Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment. Journal of Alzheimer's Disease : Jad. 10: 391-7. PMID 17183150 DOI: 10.3233/Jad-2006-10407  0.641
2006 Todisco S, Agrimi G, Castegna A, Palmieri F. Identification of the mitochondrial NAD+ transporter in Saccharomyces cerevisiae. The Journal of Biological Chemistry. 281: 1524-31. PMID 16291748 DOI: 10.1074/Jbc.M510425200  0.316
2005 Boyd-Kimball D, Castegna A, Sultana R, Poon HF, Petroze R, Lynn BC, Klein JB, Butterfield DA. Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Research. 1044: 206-15. PMID 15885219 DOI: 10.1016/J.Brainres.2005.02.086  0.807
2004 Poon HF, Castegna A, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience. 126: 915-26. PMID 15207326 DOI: 10.1016/J.Neuroscience.2004.04.046  0.56
2004 Drake J, Petroze R, Castegna A, Ding Q, Keller JN, Markesbery WR, Lovell MA, Butterfield DA. 4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease. Neuroscience Letters. 356: 155-8. PMID 15036618 DOI: 10.1016/J.Neulet.2003.11.047  0.704
2004 Castegna A, Lauderback CM, Mohmmad-Abdul H, Butterfield DA. Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease. Brain Research. 1004: 193-7. PMID 15033435 DOI: 10.1016/J.Brainres.2004.01.036  0.769
2004 Castegna A, Thongboonkerd V, Klein J, Lynn BC, Wang YL, Osaka H, Wada K, Butterfield DA. Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. Journal of Neurochemistry. 88: 1540-6. PMID 15009655 DOI: 10.1046/J.1471-4159.2003.02288.X  0.629
2003 Butterfield DA, Castegna A. Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids. 25: 419-25. PMID 14661101 DOI: 10.1007/S00726-003-0027-7  0.644
2003 Butterfield DA, Castegna A. Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration. Cellular and Molecular Biology (Noisy-Le-Grand, France). 49: 747-51. PMID 14528911  0.647
2003 Butterfield DA, Boyd-Kimball D, Castegna A. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. Journal of Neurochemistry. 86: 1313-27. PMID 12950441 DOI: 10.1046/J.1471-4159.2003.01948.X  0.787
2003 Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA. Proteomic identification of nitrated proteins in Alzheimer's disease brain. Journal of Neurochemistry. 85: 1394-401. PMID 12787059 DOI: 10.1046/J.1471-4159.2003.01786.X  0.676
2003 Lauderback CM, Drake J, Zhou D, Hackett JM, Castegna A, Kanski J, Tsoras M, Varadarajan S, Butterfield DA. Derivatives of xanthic acid are novel antioxidants: application to synaptosomes. Free Radical Research. 37: 355-65. PMID 12747729 DOI: 10.1080/1071576021000040664  0.741
2003 Butterfield D, Castegna A, Pocernich C, Drake J, Scapagnini G, Calabrese V. Erratum: Nutritional approach to combat oxidative stress in Alzheimer's disease (review) (Journal of Nutritional Biochemistry (August 2002) 13:8 (444-461)) Journal of Nutritional Biochemistry. 14. DOI: 10.1016/S0955-2863(03)00175-X  0.773
2002 Butterfield DA, Castegna A, Lauderback CM, Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiology of Aging. 23: 655-64. PMID 12392766 DOI: 10.1016/S0197-4580(01)00340-2  0.792
2002 Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. Journal of Neurochemistry. 82: 1524-32. PMID 12354300 DOI: 10.1046/J.1471-4159.2002.01103.X  0.646
2002 Butterfield DA, Castegna A, Drake J, Scapagnini G, Calabrese V. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutritional Neuroscience. 5: 229-39. PMID 12168685 DOI: 10.1080/10284150290028954  0.742
2002 Butterfield D, Castegna A, Pocernich C, Drake J, Scapagnini G, Calabrese V. Nutritional approaches to combat oxidative stress in Alzheimer's disease. The Journal of Nutritional Biochemistry. 13: 444. PMID 12165357 DOI: 10.1016/S0955-2863(02)00205-X  0.795
2002 Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine. 33: 562-71. PMID 12160938 DOI: 10.1016/S0891-5849(02)00914-0  0.683
2001 Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends in Molecular Medicine. 7: 548-54. PMID 11733217 DOI: 10.1016/S1471-4914(01)02173-6  0.801
Show low-probability matches.